Skip to content

Author

M. Terlizzi

2 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Aug 2026

Online adaptive radiotherapy for prostate cancer: Current evidence and clinical perspectives.

Adaptive radiotherapy has emerged as a promising strategy to improve the precision of prostate cancer treatment by accounting for daily anatomical variations. Recent technological advances have enabled online treatment adaptation, particularly in the context of magnetic resonance-guided radiotherapy. This review summar...

Julie Leblanc, M. Terlizzi, Ariane Lapierre et al. · 0 citations
Review Open access Sep 2026

PSMA-targeted radioligand therapy with beta emitters in prostate cancer: current evidence, emerging indications, combination strategies, and future directions

Prostate-specific membrane antigen (PSMA)-targeted radioligand therapy (RLT) has emerged as a major therapeutic advance in metastatic castration-resistant prostate cancer (mCRPC), The phase III VISION trial demonstrated that [177Lu]Lu-PSMA-617 significantly improves overall survival and radiographic progression-free su...

H. Noamen, A. Bekkhoucha, A. Bernard-Tessier et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.